4.7 Review

New Facets of DNA Double Strand Break Repair: Radiation Dose as Key Determinant of HR versus c-NHEJ Engagement

Journal

Publisher

MDPI
DOI: 10.3390/ijms241914956

Keywords

DNA double strand breaks (DSBs); ionizing radiation (IR); homologous recombination (HR); RAD51; cancer therapy; radiation therapy

Ask authors/readers for more resources

Radiation therapy is an essential part of cancer management, utilizing different modalities of ionizing radiation to mitigate cancer progression. This article reviews the molecular mechanisms underlying the repair pathways involved in DNA damage caused by radiation therapy. It discusses factors and processes that influence the choice of repair pathways throughout the cell cycle and highlights the preference for homologous recombination at low radiation doses. The article also explores the molecular basis of transitions from high fidelity to error-prone repair pathways and analyzes the coordination and consequences of this transition on cell viability and genomic stability. Lastly, it discusses how these advances can contribute to the development of improved cancer treatment protocols in radiation therapy.
Radiation therapy is an essential component of present-day cancer management, utilizing ionizing radiation (IR) of different modalities to mitigate cancer progression. IR functions by generating ionizations in cells that induce a plethora of DNA lesions. The most detrimental among them are the DNA double strand breaks (DSBs). In the course of evolution, cells of higher eukaryotes have evolved four major DSB repair pathways: classical non-homologous end joining (c-NHEJ), homologous recombination (HR), alternative end-joining (alt-EJ), and single strand annealing (SSA). These mechanistically distinct repair pathways have different cell cycle- and homology-dependencies but, surprisingly, they operate with widely different fidelity and kinetics and therefore contribute unequally to cell survival and genome maintenance. It is therefore reasonable to anticipate tight regulation and coordination in the engagement of these DSB repair pathway to achieve the maximum possible genomic stability. Here, we provide a state-of-the-art review of the accumulated knowledge on the molecular mechanisms underpinning these repair pathways, with emphasis on c-NHEJ and HR. We discuss factors and processes that have recently come to the fore. We outline mechanisms steering DSB repair pathway choice throughout the cell cycle, and highlight the critical role of DNA end resection in this process. Most importantly, however, we point out the strong preference for HR at low DSB loads, and thus low IR doses, for cells irradiated in the G2-phase of the cell cycle. We further explore the molecular underpinnings of transitions from high fidelity to low fidelity error-prone repair pathways and analyze the coordination and consequences of this transition on cell viability and genomic stability. Finally, we elaborate on how these advances may help in the development of improved cancer treatment protocols in radiation therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available